Clinical trial
Efficacy of High-dose Intravenous Immunoglobulin Therapy for Hyperbilirubinemia…
NCT00288600 · Oswaldo Cruz Foundation, Other · Completed
Key facts
| NCT number | NCT00288600 |
|---|---|
| Title | Efficacy of High-dose Intravenous Immunoglobulin Therapy for Hyperbilirubinemia Due Rh Hemolytic Disease |
| Official title | Phase 4 Study of Use of High-dose Intravenous Immune Globulin for Prevent Hyperbilirubinemia Due Rh Hemolytic Disease in Newborns Infants |
| Lead sponsor | Oswaldo Cruz Foundation, Other |
| Collaborators | Instituto Fernandes Figueira |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hyperbilirubinemia, Erythroblastosis, Fetal |
| Intervention type | Drug |
| Interventions | Intravenous Immunoglobulin, Normal saline solution |
| Enrollment | 92 |
| Start date | Oct 1, 2006 |
| Primary completion | Jun 1, 2010 |
| Completion | Aug 1, 2010 |
| First posted | Feb 8, 2006 |
| Last update posted | Jan 8, 2016 |
| Countries | Brazil |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: